棒杰股份(002634) - 2018 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2018 was ¥94,709,553.86, representing an increase of 18.68% compared to ¥79,802,509.02 in the same period last year[8] - Net profit attributable to shareholders decreased by 36.43% to ¥5,113,009.84 from ¥8,042,486.08 year-on-year[8] - Basic and diluted earnings per share both dropped by 50.00% to ¥0.01 from ¥0.02 in the same period last year[8] - The weighted average return on equity decreased to 0.74% from 1.20% year-on-year, a decline of 0.46%[8] - Interest income decreased by 37.22% to CNY 2,854,780.72 from CNY 4,547,580.53, primarily due to a reduction in loan interest income from the subsidiary[16] - The net profit attributable to shareholders for the first half of 2018 is expected to range from CNY 1,472.06 million to CNY 2,491.17 million, reflecting a decrease of 35.00% to an increase of 10.00% compared to the same period last year[21] Cash Flow and Assets - The net cash flow from operating activities was negative at -¥23,998,904.74, a decline of 241.79% compared to ¥16,925,431.97 in the previous year[8] - The total assets at the end of the reporting period were ¥1,129,845,378.96, down 1.69% from ¥1,149,236,720.40 at the end of the previous year[8] - The net assets attributable to shareholders increased by 0.74% to ¥696,060,171.89 from ¥690,947,162.05 at the end of the previous year[8] - The company's construction in progress increased by 102.77% to CNY 14,023,134.37, primarily due to new expenditures on factory and headquarters construction[16] - The total amount of other current assets decreased by 85.27% to CNY 2,238,415.34, mainly due to a reduction in bank wealth management products[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,795[12] - The largest shareholder, Tao Jianwei, holds 37.50% of the shares, with 172,867,500 shares, of which 129,650,625 are pledged[12] Investments and Financial Expenses - The company plans to invest CNY 30 million in the Jiangsu Diquan Gaotejia Medical Industry Investment Fund, with an initial contribution of CNY 15 million already completed[18] - The company's financial expenses surged by 357.46% to CNY 2,489,100.54, mainly due to increased exchange losses from currency fluctuations[16] Non-Operating Income and Commitments - The company reported non-operating income and expenses totaling -¥27,201.55 for the period[9] - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[20]